Naoyuki Anzai, MD, PhD

Takatsuki Red Cross Hospital
Department of Hematology and Oncology
Takatsuki Japan Papers:
3305 Phase II Trial of Bortezomib-Based Induction, Autologous Stem Cell Transplantation, Bortezomib-Based Consolidation, and Bortezomib Maintenance in Newly Diagnosed Multiple Myeloma in Japan